Investors searching for the holy grail of promising stocks have reason to rejoice today. The esteemed Zacks Rank has anointed five stocks with its coveted #1 (Strong Buy) status. Let’s delve into why these companies are making waves in the stock market.
ADMA Biologics, Inc. ADMA: This biopharmaceutical company has been on an upward trajectory, with the Zacks Consensus Estimate for its current year earnings soaring by an impressive 33.3% over the last 60 days.
ADMA Biologics Inc Price and Consensus
ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote
Inhibikase Therapeutics, Inc. IKT: This clinical-stage pharmaceutical company is also on the rise, with the Zacks Consensus Estimate for its current year earnings surging by nearly 16% over the last 60 days.
Inhibikase Therapeutics, Inc. Price and Consensus
Inhibikase Therapeutics, Inc. price-consensus-chart | Inhibikase Therapeutics, Inc. Quote
YPF Sociedad Anónima YPF: This international energy company has been a shining beacon, with the Zacks Consensus Estimate for its current year earnings rising by a robust 24.2% over the last 60 days.
YPF Sociedad Anonima Price and Consensus
YPF Sociedad Anonima price-consensus-chart | YPF Sociedad Anonima Quote
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company is proving its mettle, with the Zacks Consensus Estimate for its current year earnings inching up by 7% over the last 60 days.
Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote
Ekso Bionics Holdings, Inc. EKSO: This exoskeleton products company is flexing its muscles, with the Zacks Consensus Estimate for its current year earnings leaping by 25.6% over the last 60 days.
Ekso Bionics Holdings, Inc. Price and Consensus
Ekso Bionics Holdings, Inc. price-consensus-chart | Ekso Bionics Holdings, Inc. Quote
You can view the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Just Released: Zacks Top 10 Stocks for 2024
Seeking the crème de la crème of stocks? Look no further. The Zacks Top 10 Stocks for 2024, meticulously curated by Zacks Director of Research, Sheraz Mian, have delivered outstanding performance. From its inception in 2012 through November 2023, the Zacks Top 10 Stocks surged by a whopping +974.1%, nearly tripling the S&P 500’s +340.1%.
Sheraz Mian has sifted through 4,400 companies assessed by the Zacks Rank and cherry-picked the top 10 stocks with immense potential for 2024. Don’t miss the chance to be among the first to lay eyes on these newly unveiled stocks.
YPF Sociedad Anonima (YPF) : Free Stock Analysis Report
ADMA Biologics Inc (ADMA) : Free Stock Analysis Report
Ekso Bionics Holdings, Inc. (EKSO) : Free Stock Analysis Report
Anavex Life Sciences Corp. (AVXL) : Free Stock Analysis Report
Inhibikase Therapeutics, Inc. (IKT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
